Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Bacterial Killing Activity of Polymorphonuclear Myeloid-Derived Suppressor Cells Isolated From Tumor-Bearing Dogs.

Hlavaty SI, Chang YM, Orth RP, Goulian M, Planet PJ, Thamm DH, Punt JA, Garden OA.

Front Immunol. 2019 Oct 10;10:2371. doi: 10.3389/fimmu.2019.02371. eCollection 2019.

2.

Identification of a Multipotent Progenitor Population in the Spleen That Is Regulated by NR4A1.

Mumau MD, Vanderbeck AN, Lynch ED, Golec SB, Emerson SG, Punt JA.

J Immunol. 2018 Feb 1;200(3):1078-1087. doi: 10.4049/jimmunol.1701250. Epub 2017 Dec 27.

3.

The orphan nuclear receptor NR4A1 specifies a distinct subpopulation of quiescent myeloid-biased long-term HSCs.

Land RH, Rayne AK, Vanderbeck AN, Barlowe TS, Manjunath S, Gross M, Eiger S, Klein PS, Cunningham NR, Huang J, Emerson SG, Punt JA.

Stem Cells. 2015 Jan;33(1):278-88. doi: 10.1002/stem.1852.

4.

NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis.

Hanna RN, Shaked I, Hubbeling HG, Punt JA, Wu R, Herrley E, Zaugg C, Pei H, Geissmann F, Ley K, Hedrick CC.

Circ Res. 2012 Feb 3;110(3):416-27. doi: 10.1161/CIRCRESAHA.111.253377. Epub 2011 Dec 22.

5.

GSK3-mediated instability of tubulin polymers is responsible for the failure of immature CD4+CD8+ thymocytes to polarize their MTOC in response to TCR stimulation.

Cunningham NR, Hinchcliff EM, Kutyavin VI, Beck T, Reid WA, Punt JA.

Int Immunol. 2011 Nov;23(11):693-700. doi: 10.1093/intimm/dxr076. Epub 2011 Sep 20.

6.

The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes.

Hanna RN, Carlin LM, Hubbeling HG, Nackiewicz D, Green AM, Punt JA, Geissmann F, Hedrick CC.

Nat Immunol. 2011 Jul 3;12(8):778-85. doi: 10.1038/ni.2063.

7.

Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.

Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, Cox T, Chong WK, Campbell RH, Bailey CC, Gattamaneni R, Picton S, Thorpe N, Mallucci C, English MW, Punt JA, Walker DA, Ellison DW, Machin D; Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee.

Lancet Oncol. 2007 Aug;8(8):696-705.

PMID:
17644039
8.

Immature CD4+CD8+ thymocytes and mature T cells regulate Nur77 distinctly in response to TCR stimulation.

Cunningham NR, Artim SC, Fornadel CM, Sellars MC, Edmonson SG, Scott G, Albino F, Mathur A, Punt JA.

J Immunol. 2006 Nov 15;177(10):6660-6.

9.

Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.

Dumortier A, Jeannet R, Kirstetter P, Kleinmann E, Sellars M, dos Santos NR, Thibault C, Barths J, Ghysdael J, Punt JA, Kastner P, Chan S.

Mol Cell Biol. 2006 Jan;26(1):209-20.

10.

Intradural cerebellar chordoma in a child: a case report and review of the literature.

Dow GR, Robson DK, Jaspan T, Punt JA.

Childs Nerv Syst. 2003 Mar;19(3):188-91. Epub 2003 Feb 26. Review.

PMID:
12644872
11.

Neuroimaging for non-accidental head injury in childhood: a proposed protocol.

Jaspan T, Griffiths PD, McConachie NS, Punt JA.

Clin Radiol. 2003 Jan;58(1):44-53.

PMID:
12565205
12.

Cutting edge: identification of the targets of clonal deletion in an unmanipulated thymus.

Cho HJ, Edmondson SG, Miller AD, Sellars M, Alexander ST, Somersan S, Punt JA.

J Immunol. 2003 Jan 1;170(1):10-3.

13.

An invitation to T and more: notch signaling in lymphopoiesis.

Allman D, Punt JA, Izon DJ, Aster JC, Pear WS.

Cell. 2002 Apr;109 Suppl:S1-11. Review.

14.

Deciphering the role of Notch signaling in lymphopoiesis.

Izon DJ, Punt JA, Pear WS.

Curr Opin Immunol. 2002 Apr;14(2):192-9. Review.

PMID:
11869892
15.

Differential requirement for SLP-76 domains in T cell development and function.

Myung PS, Derimanov GS, Jordan MS, Punt JA, Liu QH, Judd BA, Meyers EE, Sigmund CD, Freedman BD, Koretzky GA.

Immunity. 2001 Dec;15(6):1011-26.

16.

Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells.

Allman D, Karnell FG, Punt JA, Bakkour S, Xu L, Myung P, Koretzky GA, Pui JC, Aster JC, Pear WS.

J Exp Med. 2001 Jul 2;194(1):99-106.

17.

Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength.

Izon DJ, Punt JA, Xu L, Karnell FG, Allman D, Myung PS, Boerth NJ, Pui JC, Koretzky GA, Pear WS.

Immunity. 2001 Mar;14(3):253-64.

18.

Double break-point in the match for the mutator.

Owen JA, Punt JA.

Trends Immunol. 2001 Feb;22(2):69. No abstract available.

PMID:
11286698
19.

Neurological deterioration years after closure of myelomeningocoele - 'the second lesion'.

Macarthur DC, Punt JA, Spencer M, Douglas DL, White BD, Holland IM.

Spinal Cord. 2001 Jan;39(1):11-4. No abstract available.

PMID:
11224008
20.

Third ventricular cysts and membranes unsuspected on conventional CT and MRI.

MacArthur DC, Robertson IJ, Punt JA.

Br J Neurosurg. 2000 Oct;14(5):455-7.

PMID:
11198767
21.

Life rafts for thymocytes

Punt JA.

Immunol Today. 2000 Nov;21(11):530-1. No abstract available.

PMID:
11094253
22.

Immature CD4+CD8+ thymocytes do not polarize lipid rafts in response to TCR-mediated signals.

Ebert PJ, Baker JF, Punt JA.

J Immunol. 2000 Nov 15;165(10):5435-42.

23.

Paediatric brain tumours: an embryological perspective.

Scotting PJ, Thompson SL, Punt JA, Walker DA.

Childs Nerv Syst. 2000 May;16(5):261-7; discussion 268. Review.

PMID:
10883369
24.

Assessing apoptosis of developing T cells by flow cytometry.

Bishop CD, Jost A, Crane E, Punt JA.

Methods Mol Biol. 2000;134:117-31. No abstract available.

PMID:
10730253
25.

Expression of the Bcl-2 family member A1 is developmentally regulated in T cells.

Tomayko MM, Punt JA, Bolcavage JM, Levy SL, Allman DM, Cancro MP.

Int Immunol. 1999 Nov;11(11):1753-61.

PMID:
10545479
26.

Receptor avidity and costimulation specify the intracellular Ca2+ signaling pattern in CD4(+)CD8(+) thymocytes.

Freedman BD, Liu QH, Somersan S, Kotlikoff MI, Punt JA.

J Exp Med. 1999 Oct 4;190(7):943-52.

27.

Clinical management of brain stem glioma.

Walker DA, Punt JA, Sokal M.

Arch Dis Child. 1999 Jun;80(6):558-64. Review. No abstract available.

28.

Positive selection as a developmental progression initiated by alpha beta TCR signals that fix TCR specificity prior to lineage commitment.

Bhandoola A, Cibotti R, Punt JA, Granger L, Adams AJ, Sharrow SO, Singer A.

Immunity. 1999 Mar;10(3):301-11.

29.

Lesson of the week: tethered cord syndrome after myelomeningocoele repair.

Jeelani NO, Jaspan T, Punt JA.

BMJ. 1999 Feb 20;318(7182):516-7. No abstract available.

30.

Altered functional responsiveness of thymocyte subsets from CD3delta-deficient mice to TCR-CD3 engagement.

Dave VP, Keefe R, Berger MA, Drbal K, Punt JA, Wiest DL, Alarcon B, Kappes DJ.

Int Immunol. 1998 Oct;10(10):1481-90.

PMID:
9796915
31.
33.

Developmentally regulated expression of peanut agglutinin (PNA)-specific glycans on murine thymocytes.

Wu W, Punt JA, Granger L, Sharrow SO, Kearse KP.

Glycobiology. 1997 Apr;7(3):349-56.

PMID:
9147043
34.
36.

Identification of CD8 as a peanut agglutinin (PNA) receptor molecule on immature thymocytes.

Wu W, Harley PH, Punt JA, Sharrow SO, Kearse KP.

J Exp Med. 1996 Aug 1;184(2):759-64.

37.

Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy.

Bessell EM, Graus F, Punt JA, Firth JL, Hope DT, Moloney AJ, Lopez-Guillermo A, Villa S.

J Clin Oncol. 1996 Mar;14(3):945-54.

PMID:
8622044
38.

Identification of Kv1.1 expression by murine CD4-CD8- thymocytes. A role for voltage-dependent K+ channels in murine thymocyte development.

Freedman BD, Fleischmann BK, Punt JA, Gaulton G, Hashimoto Y, Kotlikoff MI.

J Biol Chem. 1995 Sep 22;270(38):22406-11.

42.

Sudden contralateral deafness following cerebellopontine angle tumor surgery.

Walsh RM, Murty GE, Punt JA, O'Donoghue GM.

Am J Otol. 1994 Mar;15(2):244-6.

PMID:
8172310
43.

Transition from TCR-beta dimer to TCR-alpha beta-expressing cells by introduction of an alpha-chain in an immature thymocyte cell line.

Kuwabara I, Ohno H, Punt JA, Hashimoto Y, Saito T.

J Immunol. 1994 Mar 1;152(5):2148-56.

PMID:
8133031
44.
45.
46.

Management and outcome of severe head injuries in the Trent region 1985-90.

Elias-Jones AC, Punt JA, Turnbull AE, Jaspan T.

Arch Dis Child. 1992 Dec;67(12):1430-5.

47.

Cerebral contusional tears as a marker of child abuse--detection by cranial sonography.

Jaspan T, Narborough G, Punt JA, Lowe J.

Pediatr Radiol. 1992;22(4):237-45.

PMID:
1523042
48.

Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins.

Punt JA, Kubo RT, Saito T, Finkel TH, Kathiresan S, Blank KJ, Hashimoto Y.

J Exp Med. 1991 Oct 1;174(4):775-83.

49.

Risks associated with giving benzodiazepines to patients with acute neurological injuries.

Eldridge PR, Punt JA.

BMJ. 1990 May 5;300(6733):1189-90. No abstract available.

50.

Brain abscess in the 1980s.

Donald FE, Firth JL, Holland IM, Hope DT, Ispahani P, Punt JA.

Br J Neurosurg. 1990;4(4):265-71.

PMID:
2222873

Supplemental Content

Support Center